Viral Vectors Capabilities Updates
-
Viralgen Capabilities Update September 2026: Viral Vectors
10/1/2026
Standardized AAV manufacturing platforms accelerate gene therapy development from concept to IND, reducing risk, simplifying processes, and supporting efficient scale-up.